The major enzyme isoform that synthesizes nitric oxide (NO) in first trimester human placentae is endothelial or type III NO-synthase (NOS III) which exhibits high specific activity in the microsomal fraction. In the present study, we investigated the possible protective and enzyme-stabilizing role of tetrahydropterin (BH 4 ). The anionic detergent, sodium dodecyl sulphate (SDS) and thermal stress (freeze-thaw) were used as non-specific 'subunit-dissociating' agents, and alterations in enzyme activity and subunit structure were investigated. SDS (ജ0.05% w/v) resulted in significant inhibition both of basal and BH 4 -stimulated activities of NOS III, but the latter responded more sensitively. Preincubation of microsomes with SDS (ജ0.1%, w/v), followed by incubation in an SDS-depleted reaction mixture led to an inhibition of BH 4 -stimulated enzyme activity, while no change in the basal activity was noted. This indicated that the SDS effect is only fully reversible in the case of basal activity. Considering that basal activity is due to the presence of endogenous BH 4 tightly bound to the enzyme, this differential sensitivity of basal and BH 4 -stimulated enzyme activities to SDS may be related to a putative differerential protective effect of BH 4 on the two subunits of the NOS III dimer. Western blot analysis revealed that the SDS-induced inhibition of enzyme activity could not be ascribed to disruption of the dimeric structure. This finding confirms the view that SDS may affect NOS III activity without necessarily deteriorating quaternary protein structure. Nevertheless, BH 4 is essential in maintaining dimeric structure under denaturing conditions, e.g. SDS treatment and freezing/thawing; it is even able to reverse the dissociation caused by SDS. A model describing the interaction between BH 4 and NOS III, and its implications on the physiology and pathology of the human placenta, is discussed.
Introduction
The first-trimester human placenta contains a predominantly membrane-bound, Ca 2ϩ -dependent nitric oxide synthase (NOS) activity exhibited by an endothelial or type III NOS isoform (Kukor and Tóth, 1994; Rutherford et al., 1995; Tóth et al., 1995; Ramsey et al., 1996) . Elucidation of the mechanisms of regulation of this enzyme activity may shed some light on the poorly understood physiological significance of nitric oxide (NO) production in early placenta. Placental NOS activity seems to be controlled by a dual pathway, involving concentration changes of Ca 2ϩ and tetrahydrobiopterin (BH 4 ). In placental homogenates, the activating action of Ca 2ϩ occurs within narrow concentration limits (70-400 nM), with a half maximal stimulation at~200 nM, both in the presence and the absence of BH 4 . The presence of Ca 2ϩ is indispensable for enzyme activity, whereas the addition of BH 4 to homogenates containing Ca 2ϩ in concentrations of ജ200 nM results in a further 2-2.5-fold activation (Kukor et al., 1996) . We have observed a striking difference between cytosolic and microsomal NOS III in terms of the BH 4 -induced increment of enzyme activity. In response to 50 µM BH 4 , microsomal enzyme activity is increased by as much as six-fold, whereas cytosolic enzyme activity is increased only two-fold relative to the activity of preparations incubated without BH 4 (Sahin- Tóth et al., 1997) . Compartment-specific action of BH 4 represents a novel regulatory mechanism for regulating placental NOS activity. The BH 4 -promoted activation of the microsomal enzyme is attended by formation of dimer-like aggregates that are stable in ice-cold solutions of electrophoresis sample buffer containing 2% sodium dodecyl sulphate (SDS). In order to gain an insight into the physiological relevance of the dramatic effects of BH 4 on the microsomal enzyme, we determined the average concentration of BH 4 in the early placental tissue and compared it with the concentrations that cause enzyme activation and dimerization in the placental microsome fraction . The average tissue concentration of BH 4 (207 Ϯ 87 nM, Kukor et al., 1996) is in the half-maximal activating (79 nM) and the halfmaximal dimerizing (148 Ϯ 33 nM) concentration ranges, strongly suggesting a physiological role for BH 4 in the regulation of type III NOS activity in the primordial human placenta .
In order to gain more information on the relationship between the structural (dimerizing) and functional (activating) effects of BH 4 on placental NOS III, we explored the possible protecting and stabilizing action of BH 4 on subunit structure and enzyme activity against stress caused by SDS and freezing/thawing.
Materials and methods
Reagents L-[2,3,4,5-3 H]-arginine-HCl (67 Ci/mmol; 2,37 TBq/nmol) and ECL chemiluminescent immunoblot reagent were purchased from Amersham International (Chalfont, Bucks, UK). (6R)-5,6,7,8-tetrahydro-L-biopterin-2HCl (BH 4 ) was obtained from Research Biochemicals International (Natick, MA, USA). Monoclonal anti-NOS III antiserum was from Transduction Laboratories (Lexington, KY, USA). Horseradish peroxidase-conjugated antimouse goat immunoglobulin (Ig)G, N G -nitroarginine methylester (NAME), SDS, ethyleneglycol-bis (β-aminoethylether)-N-tetraacetate (EGTA), NADPH, Dowex 50X8-400, dithiothreitol (DTT), citrulline, calmodulin, glycine, valine and leupeptin were all obtained from Sigma Chemical Co. (St Louis, MO, USA). Phenylmethylsulphonylfluoride (PMSF) and HEPES were from Calbiochem (La Jolla, CA, USA), aprotinin from Bayer Co (Leverkusen, Germany). Soybean trypsin inhibitor, acrylamide, methylene-bis-acrylamide, EDTA and other chemicals were from Reanal (Budapest, Hungary). Nitrocellulose membrane and prestained molecular mass markers were purchased from BioRad (Vienna, Austria).
Tissue, homogenization and fractionation
First trimester human placentae were obtained from legal instrumental termination of 9-11 week old pregnancies at the 2nd Department of Obstetrics and Gynecology, Semmelweis Medical University, Budapest, Hungary. The use of the tissue for these experiments was approved by the Ethics Committee of the Medical Section of Hungarian Academy of Sciences. Macroscopically-isolated placental tissue mince was homogenized in 2 volumes of ice-cold homogenizing solution containing 0.3 M sucrose, 40 mM HEPES-Na, pH 7.4, 0.1 mM EDTA, 1 mM DTT, 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor and 0.2 µg/ml aprotinin, using an UltraTurrax apparatus (IKA Werk, Staufen, Germany) at the threequarter setting for 30 s. The homogenate was filtered through a nylon mesh and heavy particulate material and mitochondria were sedimented at 15 000 g for 30 min in a Beckman J-21 centrifuge. The supernatant was centrifuged at 100 000 g for 60 min in a Beckman L2-75B ultracentrifuge to obtain the microsomal pellet. The pellet was suspended in homogenizing solution and used for incubation immediately.
Measurement of NO-synthase activity
Determination of NOS activity was performed by measuring the rate of conversion of [ 3 H]-arginine into [ 3 H]-citrulline. Detailed description of the procedure has been reported Tóth et al., 1997) . Briefly, 70-90 µg microsomal protein was incubated with 0.4 mM NADPH, 1 mM citrulline, 1 mM MgCl 2 , 16 mM Lvaline, 25 µM free Ca 2ϩ , 3 IU calmodulin, 2 µM BH 4 , 0.75 µCi [ 3 H]-arginine (47 nM final concentration), 20 mM HEPES-Na, pH 7.4 and SDS as indicated, in 250 µl final volume for 10 min at 37°C. Free Ca 2ϩ -concentration of the incubates was adjusted with Ca 2ϩ -EGTA buffer (Bártfai, 1979) . Control incubates contained 1 mM NAME and 1 mM EGTA without added Ca 2ϩ . [ 3 H]-citrulline was separated from [ 3 H]-arginine using small columns of Dowex 50X8-400 cation exchange resin. Radioactivities were corrected for the count/min value obtained as the mean of controls. NOS activity was finally calculated as pmol citrulline/min/mg microsomal protein. In order to study the effect of SDS on the subunit structure of NOS, parallel to the incubations with [ 3 H]-arginine, the complete reaction mixture was incubated under entirely identical conditions, but without the labelled arginine, and the mixture was applied for Western blot analysis as described below.
Immunoblotting
Incubated microsomes were mixed with an equal volume (250 µl) of 'sample buffer', so as to obtain final concentrations of 50 mM Tris-HCl, pH 6.8, 0.1% bromophenolblue, 10% glycerol, 10 mM dithiothreitol and SDS in w/v percentage equivalent to that in the incubated mixture. Samples were kept at -80°C in a Kelvinator freezer (ASSAB, Spanga, Sweden), they were thawed in an ice bath on the day of analysis (usually within 1 week of incubation), vortex mixed thoroughly, and 25 µl aliquots were electrophoresed for 4 h, on 7.5% acrylamide, 0.2% methylene-bis-acrylamide gels using 29 mA current. Stacking and separation gels and the running buffer contained 0.1% SDS. During sample application and running, the electrophoresis vessel (Miniprotean II; Bio-Rad) was placed in an ice bath. Proteins were transferred to nitrocellulose membranes for 2 h at 290 mA and the membranes were blocked overnight at 4°C with TBST solution (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1% Tween 20) containing 5% dissolved low fat milk powder (TBST-M solution). The membranes were then exposed to monoclonal type III NOS antibody dissolved in TBST solution and used at a dilution of 1:1000 at room temperature for 2.5 h. After four successive washes with 15 ml TBST for 5 min each, peroxidase conjugated secondary antibody (goat anti mouse IgG dissolved in TBST-M solution) was added at 1:6000 dilution and the membranes were incubated for 1 h at room temperature. Following four washes with 15 ml TBST solution as above and finally with distilled water, the membranes were immersed in enhanced chemiluminescence (ECL) solution for 1 min, excess reagent was removed with filter paper, the membranes placed between transparent polyethylene sheets and exposed to Reflection autoradiography film (Dupont, Boston, MA, USA) for 12 min, except where stated otherwise.
Protein determination
Protein was measured as described by Lowry et al. (1951) using bovine serum albumin as standard.
Statistical analysis
Student's paired t-test was used for statistical evaluation of data. P Ͻ 0.05 was considered to be statistically significant.
Results
First, the effects of 2 µM BH 4 (final concentration) on NOS activity in the presence of various concentrations of SDS were studied (Figure 1 ). Consistent with our previous findings, BH 4 enhanced the enzyme activity 2.83-fold and low concentrations of SDS did not influence (0.005 and 0.01%, w/v) or did not significantly influence (0.02%, w/v) the basal or the BH 4 stimulated activity. At 0.005% and 0.01% SDS, the extent of BH 4 -stimulation was 3.04 and 3.00-fold respectively. At 0.02% SDS, this value decreased to 2.68. At 0.05% (w/v) concentration, SDS inhibited significantly both the basal (ϩSDS/-SDS ϭ 0.308 Ϯ 0.099, n ϭ 6, P Ͻ 0.001) and the BH 4 - stimulated (ϩSDS/-SDS ϭ 0.248 Ϯ 0.062, n ϭ 6, P Ͻ 0.001) activity. However, a 2.28-fold significant BH 4 effect was still maintained. Further elevation of SDS concentration (0.075-0.5%) led to marked (80-97%) decreases in NOS activity and the activating effect of BH 4 essentially disappeared. The observations indicate that BH 4 does not protect NOS III against SDS inhibition, and the BH 4 -stimulated enzyme is impaired more sensitively by increasing concentrations of SDS.
In further experiments, the effects of various SDS concentrations on the subunit structure of microsomal NOS III were studied by immunoblot analysis. In addition, the effect of repeated freezing and thawing was also investigated. In these experiments incubations with SDS were carried out in complete assay mixture (minus radioactive arginine) at 37°C. Each sample was then diluted with a special electrophoresis sample buffer, containing exactly the same SDS concentration as the incubation mixture. Samples were frozen at -80°C, thawed on ice and electrophoresed on polyacrylamide gels containing 0.1% SDS. It is important to note that the 0.1% SDS included in the ice-cold gel and running buffers had no significant effect on subunit structure ( Figure 2 , lane 1). The experiments were run in parallel with the enzyme activity measurements using the same batch of enzyme preparations and, hence, the immunoblot patterns and the enzyme activities obtained (Figures 1, 2 and 4) could be directly compared. The immunoblot patterns revealed two discrete immunopositive bands, corresponding to the 135 monomeric and the 210 kDa dimeric forms (Lee et al., 1995; Rodriguez-Crespo et al., 1996; Sahin-Tóth et al., 1997; Tóth et al., 1997; Venema et al., 1997) of NOS-type III enzyme. In various experiments the relative intensity of the 3, 4 , and 5 respectively) in the absence or presence of 2 µM BH 4 . After incubation each mixture was diluted with an equal volume of 2ϫ concentration sample buffer containing SDS in a concentration identical to that in the corresponding assay mixture. The mixtures were immediately deep frozen (-80°C) and 25 µl portions (70 µg protein) were electroblotted after (A) one or (B) three freeze-thaw cycles with 2-4 days duration between thawings. Chemiluminescent protein bands produced on nitrocellulose membranes were made visible by exposure to immunoblot films for (A) 12 and (B) 8 min. *The immunopositive bands correspond to the 210 kDa dimeric form and the 135 kDa monomeric form of NOS III. Parallel enzyme activity determination performed without SDS showed a 2.97 Ϯ 0.15-fold increase (mean Ϯ SD, n ϭ 3) in the presence of BH 4 relative to the mean of triplicate determinations performed in the absence of BH 4 . monomeric and dimeric band showed one of two typical patterns. In numerous preparations, the dimeric form predominated (Figure 2 , lane 1) either in the presence or absence of BH 4 and irrespective of the number of freeze-thaw cycles. Incubations with increasing concentrations of SDS without added BH 4 resulted in partial dissociation (Figure 2 , upper panel, A) which was further promoted to complete dissociation after three freeze-thaw cycles (Figure 2, upper panel, B) . Inclusion of 2 µM BH 4 protected the dimers against the dissociating effect of SDS, even after three freeze-thaw cycles (Figure 2 , lower panel, A and B). Interestingly, no direct correlation was observed between the effects of SDS on enzyme activity and subunit dissociation, indicating that impaired enzyme activity cannot be ascribed entirely to . Placental microsomes were incubated at 37°C for 10 min in complete NOS activity assay mixture (except radioactive arginine) with no SDS added (lane 1) or with 0.05 and 0.5% (w/v) final concentration of SDS (lanes 2 and 3, respectively). After incubation the mixtures were diluted with 2ϫ concentration sample buffer containing SDS in concentrations identical to those in the assay mixtures. Subsequently, samples were frozen at -80°C. Electroblotting was performed after two freeze-thaw cycles using 25 µl mixture (70 µg protein). BH 4 was added in 1 µM final concentration to 50 µl aliquots of each sample mixture, vortex mixed, and kept at 4°C for 30 min before electroblotting. Nitrocellulose membranes with chemiluminescent protein bands were exposed to immunoblot films for 12 min. *The immunopositive bands correspond to the 210 kDa dimeric form and the 135 kDa monomeric form of NOS III. dissociation of subunits. For instance, in the presence of BH 4 and 0.1 or 0.2% SDS, the dimeric form was still maintained whereas the enzyme activity practically disappeared. Figure 3 shows that the SDS-induced subunit dissociation can be reversed by subsequent addition of BH 4 . In this experiment, microsomal NOS-type III was first partially or completely dissociated by treatment with 0.05 and 0.5% SDS respectively, and employing two freeze-thaw cycles. BH 4 was then added at 1 µM final concentration, and samples were electrophoresed and immunoblotted. The results clearly indicate that BH 4 added to the dissociated NOS III was able to reassociate the monomeric units.Therefore, BH 4 is not only able to stabilize the dimer and prevent its dissociation but it can also promote the re-association of monomers efficiently even in the presence of SDS.
In other preparations, the majority of NOS III observed on immunoblots was found in monomeric form, even in the absence of SDS during incubation (Figure 4 ). These preparations exhibited comparable basal and BH 4 -stimulated activities to those where dimers were the dominant enzyme form (e.g. Figures 1 and 2) . BH 4 induced robust dimerization in these preparations irrespective of whether it was added to the incubation mixture (Figure 4, lower panel) or to the electrophoresis sample buffer (Figure 4, upper panel, right) . Taken together with previous findings, the observations demonstrate that BH 4 acts by stabilizing the relatively loosely assembled dimers (Figure 2) or by promoting dimer assembly from monomers ( Figure 4) . Figure 4 also demonstrates that incuba-1168 tion with 1.0% SDS at 37°C irreversibly dissociates the NOS III dimers and BH 4 does not restore the dimer structure. It should be noted that similar SDS concentrations do not influence the enzyme structure when incubated at 4°C.
The effect of preincubation of NOS-type III with SDS on enzyme activity was also studied. After a 10 min preincubation of microsomes (suspended in homogenizing buffer) with different concentrations of SDS at 37°C, the detergent concentration was reduced by diluting the mixtures 5.6-fold with buffer; the basal and BH 4 -stimulated activities were then determined by standard assay. As shown in Figure 5 , SDS pretreatment influences the two activities differently; the basal activity does not change, whereas 0.1-0.2% SDS selectively decreased the BH 4 -stimulated activity. The ratio of stimulated to basal activities is~2; at least at SDS concentrations of 0.01-0.05%. The marked inhibition of BH 4 -stimulated activity by 0.05% SDS shown in Figure 1 was not noted in this experiment, indicating that the effect of SDS applied at this concentration is reversible. Similarly, inhibition of basal enzyme activity by 0.05-0.1% SDS concentrations is fully reversible (Figures 1  and 5 ).
Immunoblot analysis of enzyme protein obtained in preincubation experiments did not show dramatic changes in response to various SDS concentrations ( Figure 6 ). However, when the patterns were compared to those obtained in experiments where SDS was added directly to the assay mixtures (Figures 2 and 4) a characteristic difference was found; in the preincubation experiments, the dimerizing effect of BH 4 was never as complete as in Figures 2 and 4 , a fraction of monomeric forms always remained unchanged as if their sensitivity to BH 4 had been lost.
Discussion
Current research on the role of NO in human pregnancy addresses three main topics with special emphasis: (i) identification of cell types and NOS isoforms involved in NO biosynthesis in the uterus, fetal membranes and placenta; (ii) activity and regulation of these enzymes at different stages of pregnancy; and (iii) the role NO plays in maintenance of pregnancy and in initiation of parturition including regulation of uterine contractility and cervical ripening (Chwalisz et al., 1996; Rosselli, 1997; Sladek et al., 1997) . Our present and previous studies (Kukor et al., 1996; Sahin-Tóth et al., 1997; Tóth et al., 1997) have focused on the molecular characterization of NOS III from human primordial placenta. We believe that in-vitro biochemical analysis of this enzyme can provide us with valuable insight into the in-vivo physiology and pathophysiology of NO in human pregnancy and parturition.
Animal models are widely used to explain the role of NOS activity in mammalian pregnancies and a vast amount of data has accumulated on NOS enzymes in reproductive tissues of the rat. Immunohistochemical and immunoblot studies have revealed that the isoforms expressed in rat placentae are the inducible NOS:NOS II (Purcell et al., 1997; Zarlingo et al., 1997) and the endothelial NOS isoform: NOS III (Zarlingo et al., 1997) . Rat placental trophoblastic cells, i.e. cells of the trophospongial cell layer, like vacuolated 'glycogen cells', Figure 4 . Effect of BH 4 on the structure of nitric oxide synthase (NOS III) at various concentrations of sodium dodecyl sulphate (SDS) in microsomal preparations containing mainly monomers. Placental microsomes were incubated at 37°C for 10 min in complete NOS activity assay mixture (except radioactive arginine) with no SDS added (lane 1) or with 0.01, 0.02, 0.05, 0.075, 0.10 and 1.00% (w/v) final concentrations of SDS (lanes 2, 3, 4, 5, 6 and 7 respectively) in the absence (top) and presence (bottom) of 2 µM BH 4 . After incubation the mixtures were diluted with 2ϫ concentration sample buffer containing SDS in concentrations identical to those in the assay mixtures and the samples were frozen at -80°C. Aliquots from four samples incubated without BH 4 but with 0.01, 0.02, 0.05 and 0.10% SDS were given 1 µM BH 4 (final concentration), vortex mixed and kept at 4°C for 30 min before electroblotting (lanes 2b, 3b, 4b and 6b respectively). 25 µl samples containing 82 µg protein were electroblotted. Nitrocellulose membranes containing chemiluminescent protein bands were exposed to immmunoblot films for 12 min. *The immunopositive bands correspond to the 210 kDa dimeric form and the 135 kDa monomeric form of NOS III. Parallel enzyme activity determination performed without SDS added, displayed a 3.29 Ϯ 0.17-fold increase (mean Ϯ SD, n ϭ 3) in the presence of BH 4 relative to the average value of triplicate determinations performed in the absence of BH 4 . Figure 5 . Effect of preincubation of placental microsomes with various concentrations of sodium dodecyl sulphate (SDS) on the basal and tetrahydrobiopterin (BH 4 )-stimulated activity of placental type-III nitric oxide synthase. Different pools of placental microsomes suspended in homogenizing solution were incubated in duplicates in six experiments for 10 min at 37°C in the presence of SDS as indicated. After incubation the mixtures were diluted 5.6-fold by homogenizing solution and 100 µl aliquots were incubated in the standard enzyme assay mixture for 10 min at 37°C in the presence (-s-) and absence (-d-) of 2 µM BH 4 . Enzyme activity was determined using the rate of conversion of small basophilic cells and trophoblastic giant cells, contain the NOS II isoform. Importantly, placental NOS II expression decreases dramatically toward term and therefore it may be 1169 an important factor contributing to the initiation of labour (Purcell et al., 1997) . It is of interest that NOS II protein Riemer et al., 1997) and NOS II mRNA (Ali et al., 1997) decrease more markedly than NOS III protein and mRNA within the whole rat uterus and specifically in the myometrium, whereas NOS II protein and mRNA increase selectively and significantly in the uterine cervix obtained from term pregnancy. These findings are in good agreement with the notion that NO synthesized by NOS II in the myometrium serves to maintain the quiescent state of the uterus, whereas cervical NOS II controls ripening of the uterine cervix. Results obtained with antiprogestin treatment indicate that progesterone up-regulates NOS II expression in the uterus and down-regulates it in the uterine cervix Ali et al., 1997) . These findings elucidate a molecular basis for the unique regulatory role this steroid plays in the pregnant uterus.
Available data on NOS distribution and regulation in human female reproductive tissues show a picture which is different from that in the rat. Although some studies have indicated comparable values of Ca 2ϩ -dependent (NOS III) and Ca 2ϩ -independent (NOS II) activities in first trimester or term placental villi Sooranna et al., 1995) , several other studies revealed NOS III as the major isoform expressed in this tissue, whereas NOS II protein and Ca 2ϩ -independent (NOS II) activity were virtually absent or showed only relatively low levels (Conrad et al., 1993; Garvey et al., 1994; Kukor and Tóth, 1994; Rutherford et al., 1995; Schönefelder et al., 1996; Sahin-Tóth et al., 1997; Zarlingo et al., 1997) . Furthermore, in contrast with the presence of NOS III mRNA, NOS II mRNA could not be detected in placentae of healthy pregnant women (Garvey et al., 1994; Schönfelder et al., 1996) but NOS II mRNA and protein were found in the placentae of women with gestational diabetes Figure 6 . Effect of tetrahydrobiopterin (BH 4 ) on the homodimer formation of placental NOS III after preincubation with various concentrations of sodium dodecyl sulphate (SDS). Placental microsomes preincubated with SDS were incubated in the presence or absence of 2 µM BH 4 as it is described in the legend to Figure 5 , except that labelled arginine was not added. The two panels illustrate two characteristic patterns with complete (upper panel) and partial (lower panel) dissociation of homodimers during SDS pretreatment. Subunit structures obtained after (A) preincubation or (B) incubation with or without BH 4 are presented. Preincubation occurred in the absence of SDS (lane 1) or in the presence of 0.02, 0.05 and 0.1% SDS (lanes 2, 3, and 4 respectively). Subsequently, SDS was diluted to negligible concentrations and incubation was performed in the absence (1a, 2a, 3a and 4a) or in the presence (1b, 2b, 3b and 4b) of 2 µM BH 4 . After preincubation and incubation each mixture was given an equal volume of 2ϫ concentration sample buffer. The samples were immediately frozen at -80°C and after thawing, portions containing 65 µg protein were electroblotted. Chemiluminescent protein bands were made visible by exposure of the blot to immunoblot films for 15 min. *The immunopositive bands correspond to the 210 kDa dimeric form and the 135 kDa monomeric form of NOS III. (Schönfelder et al., 1996) . In addition, transient expression of NOS II protein specifically in the myometrium of preterm not-in-labour pregnant women and in decidualized stromal cells of first trimester pregnancy (Telfer et al., 1997) have been reported.
Type II NOS in human placentae has been shown to reside in a small number of macrophage cells of villous stroma (Myatt et al., 1997; Zarlingo et al., 1997) , whereas NOS III is expressed in vascular endothelium and mainly in syncytiotrophoblasts (Conrad et al., 1993; Buttery et al., 1994; Zarlingo et al., 1997) . Among several species studied, only human placental (syncytio)trophoblasts were found to express NOS III (Zarlingo et al., 1997) . Therefore, the putative functions ascribed to this isoform in syncytiotrophoblasts, i.e. the prevention of platelet aggregation in the intervillous space and the adhesion of leukocytes to the trophoblast surface, an influence on maternal adaptive immune response, dilation of spiral arteries penetrating the uterine wall to intervillous space (Chwalisz et al., 1996) or regulation of peptide hormone 1170 release (Ni et al., 1997) , appear to be unique to humans (Zarlingo et al., 1997) . Therefore, the investigation of the molecular properties and biochemical characteristics of the human placental NOS III enzyme is clearly justified.
The present experiments demonstrate that SDS inhibits the activity of placental NOS-type III (endothelial or eNOS) enzyme efficiently. Concentrations of ജ0.05% diminish the activity drastically, whereas concentrations of ഛ0.02% do not show significant effects. The inhibitory action is somewhat more dramatic in the case of the BH 4 -stimulated activity, whereas at SDS concentrations of ജ0.075%, both basal and BH 4 -stimulated activity practically disappear. It seemed of interest to study the role that SDS-promoted subunit dissociation may play in the loss of enzymatic activity. Our results clearly show that BH 4 maintains the dimeric structure even at SDS concentrations that inactivate the enzyme (0.05-0.5%). However, incubation with 1% SDS leads to both inactivation and irreversible subunit segregation.
Arguably the most interesting result of this study is the observation that, over the concentration range of 0.1-0.2% SDS, BH 4 -stimulated NOS III activity is irreversibly inhibited, while inhibition of the basal activity is fully reversible. Thus, when microsomal membranes are pre-treated with SDS and the detergent concentration is subsequently lowered by dilution, basal NOS activity is fully recovered, while the stimulating effect of BH 4 is diminished in a dose-dependent manner. Now the question arises: what could the enzymatic property be that would explain such a differential response to BH 4 -stimulated and basal activities? Considering that basal NOS activity is attributed to endogenous BH 4 bound with high affinity to the enzyme, a differential protective effect of BH 4 on the two subunits of the homodimeric NOS III is a possibility. It is widely accepted that only the dimeric form of NOS is enzymatically active. Attachment of haem to the enzyme protein appears to be the only prerequisite for dimer formation List et al., 1996 List et al., , 1997 Venema et al., 1997) ; the dimer is then stabilized and activated by binding of one or two BH 4 molecules (Gorren et al., 1996; List et al., 1996) . Studies with NOS-type I (Gorren et al., 1996) and type II (Mayer et al., 1997) have indicated a strong negative cooperative interaction between the BH 4 -binding sites of the dimeric enzyme. Thus, one BH 4 bound with high affinity (K d in the low nanomolar range) to one of the binding sites markedly decreases the binding affinity of BH 4 to the second site (K d~5 0 times greater). Such an interaction would explain why a high pharmacological concentration of BH 4 (50 µM) stimulates NOS III activity by a factor of~2-times without any effect on dimer formation in the placental cytosol (Sahin- Tóth et al., 1997) , and why purified dimeric NOS enzymes retain BH 4 and haem in a 1:2 ratio . It should not escape our attention that such differential BH 4 affinity may account for the differential sensitivity of the two NOS III subunits to SDS action. Thus the subunit of the homodimeric enzyme that holds the BH 4 molecule in a tightly bound fashion might be less susceptible, whereas the subunit that is devoid of BH 4 would be more prone to inactivation by SDS. The enzyme-stabilizing function of BH 4 would support this notion. If this hypothesis (which fits in nicely with the emerging picture of NOS-BH 4 interaction) is valid, then it would offer a mechanism for a direct enzyme activating role for BH 4 ; at least in the human placenta. In primordial placental tissues, the individual variation of BH 4 values (in the range 100-300 nM; Kukor et al., 1996) , must influence NOS III activity, since the EC 50 value for BH 4 is 80 nM . Therefore, the activity of the enzyme varies with the endogenous BH 4 concentrations, which themselves vary in different individuals, thus contributing to different levels of NOS activity in these individuals. It seems justified to mention the regulation of NOS III activity by BH 4 concentrations in the placental cells. We can speculate that the physiological concentrations of BH 4 are sufficient only to saturate the high affinity sites and to keep the enzymes in homodimeric form. At the same time, a varying portion of the second binding site remains free for possible regulatory action of BH 4 .
While application of conclusions drawn from in-vitro findings to in-vivo conditions is always subject to limitations, the molecular behavior of placental NOS III under the conditions employed would allow some extrapolations and predictions for in-vivo situations. Thus, the stable basal activity may be responsible for the maintenance of a critical minimum level of NO production, even if the stimulatable activity is lost due to certain tissue damage, metabolic imbalances or intoxications. Possible conditions may include arginine depletion and hypoxic states which may result in rapid dissociation of BH 4 from the enzyme , and oxidative stress which may convert BH 4 to BH 2 and may lead this way to a decrease of BH 4 availability. Furthermore, any condition, either temporary or prolonged, that can result in an accumulation of detergentlike molecules, e.g. fatty acid anions and amphipathic lipids may inhibit the stimulatory action of BH 4 . Smoking was reported to decrease NOS activities in the placental villi and it would be interesting to see whether it affects BH 4 -stimulatable activity.
Our finding that placental microsomes contain a mixture of monomeric and dimeric forms whose proportion varies with different preparations is compatible with the finding that there is a considerable variation in BH 4 concentration among different human primordial placentae (Kukor et al., 1996) . Alternatively, certain placental microsomes may be enriched in monomeric and BH 4 -deficient dimeric forms being processed, sorted and matured. A supportive evidence in favour of this notion is the instability of the dimers in microsomes incubated without BH 4 . Thus, these dimers tend to dissociate in response to SDS and repeated freezing and thawing, but BH 4 protects and stabilizes the aggregated form (Figures 2 and 4) . The cellular level of BH 4 is crucial in maintaining the active homodimeric structure of NOS III, and expectedly the major 'subunit-dissociating' event within the cell is the decrease of BH 4 concentration. It is important to note that the in-vitro reassociating effect of BH 4 implies that NOS-type III present in the microsomal fraction of primordial human placenta contains haem, because this prosthetic group is indispensable for formation of NOS III dimers (List et al., 1997; Venema et al., 1997) .
Taken together with previous observations, our present results lead to the following model of BH 4 and NOS III interactions in the human placenta. Firstly, microsomal preparations contain a mixture of monomeric (with no BH 4 ) and dimeric (with one bound BH 4 per dimer) NOS III enzyme forms. Monomeric forms are thought to be inactive, while dimeric forms are responsible for the so-called basal enzyme activity. Addition of saturating concentration of BH 4 (ജ1 µM) will dimerize monomers and activate dimeric forms over the basal activity level. The sum of these two effects results in a 3-6-fold activation, depending on the initial monomer/dimer ratio Tóth et al., 1997) . Secondly, after incubation of microsomes at 37°C in the absence of BH 4 , only dimeric NOS III species (containing one BH 4 per dimer) remain active and these can be activated~two-fold by BH 4 ( Figure 5 ). Furthermore, sufficient concentrations of SDS (0.1-0.2%) can selectively and irreversibly inactivate the subunit lacking BH 4 , and these dimers do not respond to BH 4 stimulation.
The proposed model implies that, together with Ca 2ϩ , phosphorylation and fatty acylation, the alteration in BH 4 values is another factor modulating NOS III activity in vivo. This modulation occurs with at least two separate mechanisms: indirectly, through regulation of dimerization and directly, via an influence on enzyme activity. As discussed earlier, the molecular level explanation for such a dual regulatory role of BH 4 probably lies in the strong negative cooperative interaction of the two BH 4 binding sites on the NOS homodimer. Currently, studies are underway in our laboratory to directly demonstrate this interaction in the placental NOS III enzyme.
